AlloVir (ALVR) Short Interest Ratio & Short Volume → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free ALVR Stock Alerts $0.78 -0.01 (-1.26%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AlloVir Short Interest DataCurrent Short Volume6,400,000 sharesPrevious Short Volume6,300,000 sharesChange Vs. Previous Month+1.59%Dollar Volume Sold Short$4.78 millionShort Interest Ratio / Days to Cover8.2Last Record DateApril 15, 2024Outstanding Shares114,920,000 sharesPercentage of Shares Shorted5.57%Today's Trading Volume274,978 sharesAverage Trading Volume1,068,257 sharesToday's Volume Vs. Average26% Short Selling AlloVir ? Sign up to receive the latest short interest report for AlloVir and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALVR Short Interest Over TimeALVR Days to Cover Over TimeALVR Percentage of Float Shorted Over Time Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> AlloVir Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,400,000 shares $4.78 million +1.6%N/A8.2 $0.75 3/31/20246,300,000 shares $4.76 million +0.5%N/A5.2 $0.75 3/15/20246,270,000 shares $4.88 million +5.7%N/A3.2 $0.78 2/29/20245,930,000 shares $4.37 million +7.4%N/A2.9 $0.74 2/15/20245,520,000 shares $3.81 million +12.2%N/A2.6 $0.69 1/31/20244,920,000 shares $3.54 million +2.5%N/A2.3 $0.72 Get the Latest News and Ratings for ALVR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,800,000 shares $3.34 million -37.7%N/A2.4 $0.70 12/31/20237,700,000 shares $5.23 million -32.0%N/A4.3 $0.68 12/15/202311,320,000 shares $26.83 million -1.0%N/A8.2 $2.37 11/30/202311,430,000 shares $21.49 million -1.5%N/A12.8 $1.88 11/15/202311,600,000 shares $19.49 million +2.4%N/A14.7 $1.68 10/31/202311,330,000 shares $17.00 million +1.8%N/A13.3 $1.50 10/15/202311,130,000 shares $19.14 million -2.5%N/A13.8 $1.72 9/30/202311,420,000 shares $24.55 million +28.3%N/A14.1 $2.15 9/15/20238,900,000 shares $22.34 million +7.1%N/A10.2 $2.51 8/31/20238,310,000 shares $26.01 million +7.6%N/A9.6 $3.13 8/15/20237,720,000 shares $21.15 million +4.0%N/A9.2 $2.74 7/31/20237,420,000 shares $24.41 million +1.5%N/A11.4 $3.29 7/15/20237,310,000 shares $25.59 million +0.4%N/A11.9 $3.50 6/30/20237,280,000 shares $24.75 million -1.1%N/A13.1 $3.40 6/15/20237,360,000 shares $41.00 million +1.0%N/A16.3 $5.57 5/31/20237,290,000 shares $27.48 million +3.7%N/A28.8 $3.77 5/15/20237,030,000 shares $30.09 million -2.1%N/A29 $4.28 4/30/20237,180,000 shares $24.70 million +6.9%N/A25.9 $3.44 4/15/20236,720,000 shares $26.07 million +4.0%N/A24.9 $3.88 3/31/20236,460,000 shares $25.45 million +11.6%N/A23.3 $3.94 3/15/20235,790,000 shares $29.12 million +6.8%N/A21 $5.03 2/28/20235,420,000 shares $36.59 million +20.4%N/A21.1 $6.75 2/15/20234,500,000 shares $28.08 million +5.9%N/A17.5 $6.24 1/31/20234,250,000 shares $24.57 million -2.8%N/A17.7 $5.78 1/15/20234,370,000 shares $25.61 million +1.2%N/A16.6 $5.86 12/30/20224,320,000 shares $22.16 million +2.4%N/A15.9 $5.13 12/15/20224,220,000 shares $25.57 million +0.7%N/A14.6 $6.06 11/30/20224,190,000 shares $31.47 million -1.9%N/A13.4 $7.51 11/15/20224,270,000 shares $34.16 million +0.2%N/A12.4 $8.00 10/31/20224,260,000 shares $29.52 million -6.8%N/A11.1 $6.93 10/15/20224,570,000 shares $40.90 million -1.7%N/A8.7 $8.95 9/30/20224,650,000 shares $36.69 million +8.1%N/A9.4 $7.89 9/15/20224,300,000 shares $36.08 million +3.4%N/A9 $8.39 8/31/20224,160,000 shares $31.24 million -19.9%N/A8.6 $7.51Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> ALVR Short Interest - Frequently Asked Questions What is AlloVir's current short interest? Short interest is the volume of AlloVir shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 6,400,000 shares of ALVR short. Learn More on AlloVir's current short interest. What is a good short interest ratio for AlloVir? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALVR shares currently have a short interest ratio of 8.0. Learn More on AlloVir's short interest ratio. Which institutional investors are shorting AlloVir? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AlloVir: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is AlloVir's short interest increasing or decreasing? AlloVir saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 6,400,000 shares, an increase of 1.6% from the previous total of 6,300,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does AlloVir's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to AlloVir: Curis, Inc. (1.01%), Passage Bio, Inc. (4.24%), Athira Pharma, Inc. (2.94%), Cognition Therapeutics, Inc. (0.73%), Outlook Therapeutics, Inc. (7.41%), Gritstone bio, Inc. (13.16%), Precision BioSciences, Inc. (9.69%), Instil Bio, Inc. (0.23%), bluebird bio, Inc. (29.83%), Atara Biotherapeutics, Inc. (9.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short AlloVir stock? Short selling ALVR is an investing strategy that aims to generate trading profit from AlloVir as its price is falling. ALVR shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AlloVir? A short squeeze for AlloVir occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALVR, which in turn drives the price of the stock up even further. How often is AlloVir's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALVR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CRIS Short Squeeze PASG Short Squeeze ATHA Short Squeeze CGTX Short Squeeze OTLK Short Squeeze GRTS Short Squeeze DTIL Short Squeeze TIL Short Squeeze BLUE Short Squeeze ATRA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALVR) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings